Unity Biotechnology Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
UBX Nasdaq 8731 https://unitybiotechnology.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Unity Biotechnology Inc

UNITY Biotechnology, Inc. Reports First Quarter 2023 Financial Results and Business Updates - May 9th, 2023 8:05 pm
Unity Touts Positive Data From Diabetic Macular Edema Study, Plans Head-To-Head Study With Regeneron's Eylea - Apr 24th, 2023 5:34 pm
UNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema - Apr 24th, 2023 11:00 am
UNITY Biotechnology to Host Program Update on BEHOLD, the Phase 2 Clinical Trial of UBX1325 in Patients with Diabetic Macular Edema - Apr 23rd, 2023 10:00 pm
Unity (UNX) Down on Disappointing Results From Wet AMD Study - Mar 28th, 2023 7:25 pm
UNITY Biotechnology's Wet AMD Candidate Flunks On Non-Inferiority Threshold Compared To Regeneron's Drug - Mar 27th, 2023 5:28 pm
UNITY Biotechnology Announces Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration - Mar 27th, 2023 11:30 am
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates - Mar 15th, 2023 8:05 pm
UNITY Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference - Feb 28th, 2023 9:05 pm
UNITY Biotechnology to Participate in the SVB Securities Global Biopharma Conference - Feb 15th, 2023 1:00 pm
UNITY Biotechnology to Host Investor Call to Review Data from the UBX1325 Program and Provide an Overview of the ENVISION Wet AMD Study - Feb 9th, 2023 1:00 pm
UNITY Biotechnology Reports Granting of New Employment Inducement Award - Jan 18th, 2023 1:00 pm
10 Penny Stocks That Will Make You A Millionaire - Jan 10th, 2023 3:36 pm
UNITY Biotechnology, Inc. Reports Third Quarter 2022 Financial Results and Business Updates - Nov 8th, 2022 9:10 pm
UNITY Biotechnology Announces Positive 24-Week Data from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema - Nov 1st, 2022 11:00 am
UNITY Biotechnology Announces Reverse Stock Split Effective at 5:00 PM Eastern Time Today - Oct 19th, 2022 12:30 pm
UNITY Biotechnology’s Investor and Analyst Day to Highlight UBX1325 Program in Age-Related Diseases of the Eye - Oct 11th, 2022 12:00 pm
All You Need to Know About UNITY Biotechnology, Inc. (UBX) Rating Upgrade to Strong Buy - Oct 10th, 2022 4:00 pm
UNITY Biotechnology to Host Investor and Analyst Day to Discuss Clinical Development Program for UBX1325 in Age-Related Diseases of the Eye - Oct 6th, 2022 12:00 pm
UNITY Biotechnology Completes Enrollment in Phase 2 ENVISION Study of UBX1325 in Wet Age-related Macular Degeneration - Sep 19th, 2022 12:00 pm